|
|
|
| Accelerating Bulk Harvest Testing | The combination of the Blazar® panel with rapid methods for mycoplasma, sterility and RVLP detection offers the potential to reduce the overall turnaround time for CHO bulk harvest testing from 35 days to 14 days. Read the Application Note here. |
|
|
FOCUS ON PROCESS ENGINEERING |
|
|
|
|
| Cell Culture Media Mixing In A Benchtop Single-Use Mixer | Application Note | Cytiva | Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications. |
|
|
|
| Looking Beyond Solubility And Process Performance | Article | By Ken Sneider, Greenfield Global | Solvent selection for spray-dried dispersions significantly impacts performance, scalability, and supply chains. Early, structured solvent choice is vital for successful manufacturing. |
|
|
|
|
|
|
|
| Digital Innovation And Sustainability Are Redefining Biomanufacturing | White Paper | By Dr. Harald Bradl and Dr. Fabian Vogt, Boehringer Ingelheim Biopharmaceuticals GmbH | Next Generation Manufacturing (NGM) integrates advanced process design, digital innovation, and strategic facility planning to facilitate agile, efficient, and sustainable biopharmaceutical production. |
|
|
|
|
| A Smart Path For Novel Biologics | Article | By Pawel Linke and Markus Neubauer, Roche CustomBiotech | Read more about a solution for streamlining workflow in novel biologics while collecting quality data, by combining single-use microbioreactors with advanced automation and analytical platforms. |
|
|
PROCESS ENGINEERING SOLUTIONS |
|
|
|
|
|
|
|
| Webinar: Accelerating CHO Manufacturing: From 14-Day Fed-Batch to 10-Day Intensified Fed-batch | What if you could shorten a 14-day fed-batch process to just 10 days without sacrificing product quality? This Thermo Fisher Scientific webinar explores how N-1 perfusion intensified CHO-K1 Herceptin production using standard equipment and the same medium, while scaling from Ambr 250 to 50 L. Discover practical strategies to increase throughput, flexibility, and manufacturing capacity without significant process changes. Click here to learn more. |
|
|
|
|
By Tyler Menichiello, Chief Editor, Bioprocess Online | This article captures key takeaways from a BioProcess International keynote by Preeya Boppana, director of MSAT process analytics and laboratories at AstraZeneca, titled “Transforming Biologics Manufacturing: Leveraging Predictive Analytics and Advanced Process Control for Next-Generation Operations.” | |
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|